Direkt zum Inhalt
Merck
  • Decreased bone marrow stromal cells activity involves in unilateral anterior crossbite-induced early subchondral bone loss of temporomandibular joints.

Decreased bone marrow stromal cells activity involves in unilateral anterior crossbite-induced early subchondral bone loss of temporomandibular joints.

Archives of oral biology (2014-06-16)
Ting Yang, Jing Zhang, Yukun Cao, Mian Zhang, Lei Jing, Kai Jiao, Shibin Yu, Meiqing Wang
ZUSAMMENFASSUNG

Subchondral bone loss in mandibular condyles was reported to be induced by experimentally created unilateral anterior crossbite (UAC) which altered the occlusal load distribution and hereafter the temporomandibular joint (TMJ) remodelling process. However, the initial cellular responses are poorly understood. In the present study, changes in osteoblast and osteoclast activities in TMJ subchondral bone were investigated using the rats treated with UAC. Forty rats were randomly divided into UAC and control groups, and sampled at 2 weeks after the operation. Subchondral bone loss was evaluated by micro-CT. Osteoclast and osteoblast activities were analyzed by real-time PCR. The osteoblast differentiation of the locally isolated BMSCs from TMJ subchondral bone was assessed by Alizarin red staining. The migration of BMSCs was detected by transwell assays. Compared with the age-matched controls, TMJ subchondral bone loss was observed in the UAC-treated rats (p<0.05). The osteoblast activity evaluated by real-time PCR and osteoblast number revealed by immunohistochemical staining were reduced in the TMJ subchondral bone of UAC rats (p<0.05), and the capability of proliferation, migration and osteoblast differentiation were all decreased in the locally isolated BMSCs from the UAC group (p<0.05). The present data demonstrated an involvement of reduced BMSCs activity in the initiation of the mandibular subchondral bone loss at the early stage of installation of the aberrant prostheses.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Dexamethason, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
3-Isobutyl-1-methylxanthin, ≥99% (HPLC), powder
Sigma-Aldrich
L-Ascorbinsäure, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
L-Ascorbinsäure, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
Propidiumjodid, ≥94.0% (HPLC)
Sigma-Aldrich
3-Isobutyl-1-methylxanthin, ≥99%, BioUltra
Sigma-Aldrich
L-Ascorbinsäure, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Dexamethason, ≥98% (HPLC), powder
Sigma-Aldrich
L-Ascorbinsäure, reagent grade, crystalline
USP
Ascorbinsäure, United States Pharmacopeia (USP) Reference Standard
Supelco
L-Ascorbinsäure, analytical standard
Sigma-Aldrich
L-Ascorbinsäure, reagent grade
Sigma-Aldrich
L-Ascorbinsäure, meets USP testing specifications
Sigma-Aldrich
L-Ascorbinsäure, 99%
Sigma-Aldrich
Dexamethason, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
L-Ascorbinsäure, FCC, FG
Supelco
Ascorbinsäure, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Dexamethason, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
L-Ascorbinsäure, BioUltra, ≥99.5% (RT)
Sigma-Aldrich
L-Ascorbinsäure, ACS reagent, ≥99%
Sigma-Aldrich
Propidiumjodid -Lösung
Sigma-Aldrich
Dexamethason, meets USP testing specifications
Supelco
Dexamethason, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Ascorbinsäure, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
Sigma-Aldrich
Propidiumjodid, ≥94% (HPLC)
Sigma-Aldrich
Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe, ≥97% (HPLC)
Ascorbinsäure, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
L-Ascorbinsäure, puriss. p.a., ≥99.0% (RT)
Sigma-Aldrich
L-Ascorbinsäure, tested according to Ph. Eur.
Supelco
L-Ascorbinsäure, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland